FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40831211000001100: Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2606391000001118 Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2606401000001115 Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has AMP Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Is a Tobramycin 0.3% / Dexamethasone 0.1% eye drops 5 ml true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has dispensed dose form Conventional release eye drops true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has excipient Benzalkonium chloride false Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has specific active ingredient Tobramycin true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has specific active ingredient Dexamethasone true Inferred relationship Existential restriction modifier
Dexamethasone 0.1% / Tobramycin 0.3% eye drops (Sigma Pharmaceuticals Plc) 5 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start